S&P 500   4,292.89 (+0.30%)
DOW   33,906.09 (+0.43%)
QQQ   332.37 (+0.60%)
AAPL   173.00 (+0.52%)
MSFT   292.88 (+0.33%)
META   181.00 (+0.28%)
GOOGL   122.00 (+0.26%)
AMZN   142.94 (-0.42%)
TSLA   933.62 (+3.73%)
NVDA   188.53 (+0.77%)
NIO   21.33 (+1.04%)
BABA   94.13 (-0.68%)
AMD   100.88 (+0.05%)
MU   64.56 (-0.74%)
T   18.40 (+0.71%)
CGC   3.82 (+15.76%)
GE   79.65 (-0.35%)
F   16.29 (+0.68%)
DIS   124.25 (+2.20%)
AMC   23.64 (-3.27%)
PYPL   101.45 (+0.35%)
PFE   49.44 (-1.34%)
NFLX   248.77 (-0.21%)
S&P 500   4,292.89 (+0.30%)
DOW   33,906.09 (+0.43%)
QQQ   332.37 (+0.60%)
AAPL   173.00 (+0.52%)
MSFT   292.88 (+0.33%)
META   181.00 (+0.28%)
GOOGL   122.00 (+0.26%)
AMZN   142.94 (-0.42%)
TSLA   933.62 (+3.73%)
NVDA   188.53 (+0.77%)
NIO   21.33 (+1.04%)
BABA   94.13 (-0.68%)
AMD   100.88 (+0.05%)
MU   64.56 (-0.74%)
T   18.40 (+0.71%)
CGC   3.82 (+15.76%)
GE   79.65 (-0.35%)
F   16.29 (+0.68%)
DIS   124.25 (+2.20%)
AMC   23.64 (-3.27%)
PYPL   101.45 (+0.35%)
PFE   49.44 (-1.34%)
NFLX   248.77 (-0.21%)
S&P 500   4,292.89 (+0.30%)
DOW   33,906.09 (+0.43%)
QQQ   332.37 (+0.60%)
AAPL   173.00 (+0.52%)
MSFT   292.88 (+0.33%)
META   181.00 (+0.28%)
GOOGL   122.00 (+0.26%)
AMZN   142.94 (-0.42%)
TSLA   933.62 (+3.73%)
NVDA   188.53 (+0.77%)
NIO   21.33 (+1.04%)
BABA   94.13 (-0.68%)
AMD   100.88 (+0.05%)
MU   64.56 (-0.74%)
T   18.40 (+0.71%)
CGC   3.82 (+15.76%)
GE   79.65 (-0.35%)
F   16.29 (+0.68%)
DIS   124.25 (+2.20%)
AMC   23.64 (-3.27%)
PYPL   101.45 (+0.35%)
PFE   49.44 (-1.34%)
NFLX   248.77 (-0.21%)
S&P 500   4,292.89 (+0.30%)
DOW   33,906.09 (+0.43%)
QQQ   332.37 (+0.60%)
AAPL   173.00 (+0.52%)
MSFT   292.88 (+0.33%)
META   181.00 (+0.28%)
GOOGL   122.00 (+0.26%)
AMZN   142.94 (-0.42%)
TSLA   933.62 (+3.73%)
NVDA   188.53 (+0.77%)
NIO   21.33 (+1.04%)
BABA   94.13 (-0.68%)
AMD   100.88 (+0.05%)
MU   64.56 (-0.74%)
T   18.40 (+0.71%)
CGC   3.82 (+15.76%)
GE   79.65 (-0.35%)
F   16.29 (+0.68%)
DIS   124.25 (+2.20%)
AMC   23.64 (-3.27%)
PYPL   101.45 (+0.35%)
PFE   49.44 (-1.34%)
NFLX   248.77 (-0.21%)
NASDAQ:JYNT

Joint - JYNT Stock Forecast, Price & News

$23.39
+0.86 (+3.82%)
(As of 08/15/2022 01:36 PM ET)
Add
Compare
Today's Range
$22.41
$23.51
50-Day Range
$13.25
$22.53
52-Week Range
$13.10
$111.06
Volume
3,857 shs
Average Volume
273,300 shs
Market Capitalization
$338.24 million
P/E Ratio
155.94
Dividend Yield
N/A
Price Target
$33.17

Joint MarketRank™ Forecast

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
43.1% Upside
$33.17 Price Target
Short Interest
Bearish
7.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.16mentions of Joint in the last 14 days
Based on 24 Articles This Week
Insider Trading
Acquiring Shares
$423,740 Bought Last Quarter
Proj. Earnings Growth
121.43%
From $0.14 to $0.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

303rd out of 1,128 stocks

Patent Owners & Lessors Industry

5th out of 6 stocks

JYNT stock logo

About Joint (NASDAQ:JYNT) Stock

The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Roth Capital cut their price objective on shares of Joint from $75.00 to $40.00 in a research report on Monday, May 9th. StockNews.com lowered shares of Joint from a "hold" rating to a "sell" rating in a research report on Friday. Lake Street Capital dropped their price target on shares of Joint from $100.00 to $50.00 in a research report on Friday, May 6th. Craig Hallum lowered shares of Joint from a "buy" rating to a "hold" rating and dropped their price target for the company from $90.00 to $30.00 in a research report on Friday, May 6th. Finally, DA Davidson dropped their price target on shares of Joint from $13.00 to $12.00 and set an "underperform" rating on the stock in a research report on Monday, August 8th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $33.17.

Joint Price Performance

NASDAQ:JYNT traded up $0.68 on Friday, reaching $22.53. The company's stock had a trading volume of 106,271 shares, compared to its average volume of 169,376. The firm has a market cap of $325.78 million, a PE ratio of 150.21 and a beta of 1.33. The business has a 50-day moving average price of $16.26 and a 200 day moving average price of $27.78. Joint has a 52 week low of $13.10 and a 52 week high of $111.06. The company has a current ratio of 0.87, a quick ratio of 1.25 and a debt-to-equity ratio of 0.07.

Insiders Place Their Bets

In related news, major shareholder Bandera Partners Llc purchased 6,593 shares of the firm's stock in a transaction dated Monday, June 13th. The shares were acquired at an average cost of $13.86 per share, with a total value of $91,378.98. Following the completion of the purchase, the insider now directly owns 2,111,868 shares of the company's stock, valued at $29,270,490.48. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 3.50% of the company's stock.

Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Stock News Headlines

StockNews.com Lowers Joint (NASDAQ:JYNT) to Sell
Joint (NASDAQ:JYNT) Price Target Cut to $12.00
Joint (NASDAQ:JYNT) Upgraded by Maxim Group to Buy
What is Joint Life Insurance? - Forbes
Joint (NASDAQ:JYNT) Stock Rating Upgraded by B. Riley
Preview: Joint's Earnings
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Company Calendar

Last Earnings
11/04/2021
Today
8/15/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Patent owners & lessors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JYNT
Employees
316
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$33.17
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+41.8%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
$6.58 million
Pretax Margin
1.73%

Debt

Sales & Book Value

Annual Sales
$81.19 million
Cash Flow
$0.95 per share
Book Value
$2.05 per share

Miscellaneous

Free Float
13,955,000
Market Cap
$338.24 million
Optionable
Not Optionable
Beta
1.33

Key Executives

  • Mr. Peter D. Holt (Age 63)
    CEO, Pres & Director
    Comp: $751.31k
  • Jake Singleton (Age 40)
    Chief Financial Officer
    Comp: $379.76k
  • Mr. Jorge Armenteros
    VP of Operations
  • Mr. Charles Nelles
    Chief Technology Officer
  • Dr. Steven Knauf
    Exec. Director of Chiropractic & Compliance
  • Mr. Jason Greenwood
    Chief Marketing Officer
  • Ms. Amy Karroum
    VP of HR
  • Mr. Craig P. Colmar J.D. (Age 69)
    Sec.
  • Mr. Eric Simon
    VP of Franchise Sales & Devel.
  • Ms. Manjula Sriram
    Vice Preident of Information Technology













JYNT Stock - Frequently Asked Questions

Should I buy or sell Joint stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" JYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in JYNT, but not buy additional shares or sell existing shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price forecast for 2022?

5 Wall Street research analysts have issued 1 year price targets for Joint's shares. Their JYNT share price forecasts range from $12.00 to $50.00. On average, they predict the company's share price to reach $33.17 in the next twelve months. This suggests a possible upside of 47.2% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2022?

Joint's stock was trading at $65.69 at the beginning of the year. Since then, JYNT stock has decreased by 65.7% and is now trading at $22.53.
View the best growth stocks for 2022 here
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our JYNT earnings forecast
.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) posted its quarterly earnings results on Thursday, November, 4th. The company reported $0.13 EPS for the quarter, topping the consensus estimate of $0.04 by $0.09. The company had revenue of $20.99 million for the quarter, compared to analyst estimates of $19.48 million. Joint had a net margin of 2.53% and a trailing twelve-month return on equity of 7.74%. During the same period in the prior year, the firm earned $0.11 EPS.

What guidance has Joint issued on next quarter's earnings?

Joint updated its FY 2022 earnings guidance on Thursday, August, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $98.00 million-$102.00 million, compared to the consensus revenue estimate of $99.06 million.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by a number of retail and institutional investors. Top institutional investors include Skylands Capital LLC (2.85%), Deutsche Bank AG (1.56%), Walleye Capital LLC (1.36%), Northern Trust Corp (1.03%), Renaissance Technologies LLC (0.89%) and Principal Financial Group Inc. (0.63%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $22.53.

How much money does Joint make?

Joint (NASDAQ:JYNT) has a market capitalization of $325.81 million and generates $81.19 million in revenue each year. The company earns $6.58 million in net income (profit) each year or $0.15 on an earnings per share basis.

How many employees does Joint have?

The company employs 316 workers across the globe.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The official website for the company is www.thejoint.com. The company can be reached via phone at (480) 245-5960, via email at thejoint@lhai.com, or via fax at 480-513-7989.

This page (NASDAQ:JYNT) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.